Kymera Therapeutics (KYMR) Receivables - Net (2020 - 2026)
Kymera Therapeutics (KYMR) posted Receivables - Net of $20 million for Q2 2026, down 50.0% from $40 million a year earlier.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Receivables - Net (2020 - 2026) Analysis & Trends
At the end of FY2024, Kymera Therapeutics' Receivables - Net came in at $947,000, down 95.0% from FY2023.
- Annual Receivables - Net shows a four-year compound annual growth rate of -9.8% (FY2020 to FY2024).
- In prior years, Kymera Therapeutics' Receivables - Net was $18.76 million in FY2023 (+639.5%), $2.54 million in FY2022, $135,000 in FY2021 (-90.6%) and $1.43 million in FY2020.
- Quarterly Receivables - Net has run from a low of $135,000 in Q4 2021 to a high of $40 million in Q2 2025 over five years.
- On a year-over-year basis, Receivables - Net increased in 1 of the last four quarters, with growth averaging 169.1%.
- The strongest year-over-year quarter for Receivables - Net in the past five years was Q1 2025, with growth of 885.2%; the weakest was Q4 2024, with a decline of 93.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Kymera Therapeutics | 9.27 Bn | 6.58 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 947,000.00 |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 4.12 Mn |
| Mar 31, 2023 | 3.32 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 904,000.00 |
| Mar 31, 2021 | 1.73 Mn |
| Dec 31, 2020 | 1.43 Mn |
API Access
Kymera Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();